Pharis Mohideen - 29 Jul 2025 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
DBVT
Transactions as of
29 Jul 2025
Transactions value $
-$1,030
Form type
4
Filing time
31 Jul 2025, 16:15:16 UTC
Previous filing
27 May 2025
Next filing
25 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mohideen Pharis Chief Medical Officer C/O DBV TECHNOLOGIES S.A., 107, AVENUE DE LA REPUBLIQUE, CHATILLON, FRANCE /s/ Jason Minio, Attorney-in-Fact 31 Jul 2025 0001760395

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBVT Ordinary Shares Sale -$1,030 -464 -0.42% $2.22 109,649 29 Jul 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
F2 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F3 This sales price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1549 to EURO 1.00 as of July 29, 2025.